Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study of flavopiridol in children with relapsed or refractory solid tumors or lymphomas has completed, focusing on safety and dosi…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Pharmacokinetic Study of Doxorubicin in Children With Cancer [Phase 2]
A completed Phase 2 pharmacokinetic study of doxorubicin in pediatric cancer patients, providing pharmacokinetic data for children with Wilm…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma [Phase 2]
This document reports a Phase 2 trial evaluating a monoclonal antibody therapy in combination with sargramostim for advanced neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma [Phase 2]
Phase 2 trial update of a Rebeccamycin Analog in children with relapsed or refractory neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors [Phase 2]
Phase 2 clinical trial evaluating temozolomide followed by radiation therapy in children with newly diagnosed malignant CNS tumors has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update covers the pediatric use of temozolomide in combination with peripheral stem cell transplantation for newly diagn…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy [Phase 2]
Phase 2 trial update evaluating voriconazole to prevent fungal infections in children with neutropenia after chemotherapy. The study has com…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Caspofungin Acetate in Treating Children With Fever and Neutropenia [NA]
An update on a completed clinical trial evaluating caspofungin acetate for treating infections in pediatric patients with fever and neutrope…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Irinotecan in Treating Children With Refractory Solid Tumors [Phase 2]
A Phase 2 trial evaluating irinotecan in children with refractory solid tumors has completed, with results reported by the Children's Oncolo…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission [Phase 2]
Phase 2 clinical trial evaluating monoclonal antibody therapy in children with metastatic neuroblastoma in second remission has been complet…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment [Phase 2]
Phase 2 trial evaluating oxaliplatin in young patients with recurrent solid tumors that have not responded to prior treatment has completed.…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of erlotinib and temozolomide in pediatric patients with recurrent or refractory solid tumors has c…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors [Phase 1]
Completed Phase 1 trial evaluating tanespimycin in pediatric patients with recurrent or refractory leukemia or solid tumors.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma [NA]
This document provides an update on a completed clinical trial evaluating electroacupuncture to treat delayed nausea and vomiting in childre…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma [Phase 3]
This report updates the completion status of a Phase 3 trial evaluating combination chemotherapy and peripheral stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect [Phase 1, Phase 2]
Phase I/II clinical trial updating escalating-dose melphalan with autologous stem cell support and amifostine cytoprotection across multiple…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma [Phase 1]
Phase 1 study evaluating interleukin-12 and interleukin-2 in patients with refractory or recurrent neuroblastoma; the trial status is termin…
-
CLINICAL_TRIALS research · 2013-04-09Clinical Trial Update: Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma [Phase 1]
A Phase 1 trial evaluating pyrazoloacridine with stem cell or bone marrow transplantation in young patients with high-risk disseminated or r…
-
FDA approval · 2013-03-20FDA Approved: ADREVIEW — Supplemental Application (Medi-Physics Inc.)
FDA approved a supplemental application for ADREVIEW (Iobenguane I-123) from Medi-Physics Inc. to update its labeling/indications as a radio…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients [Phase 2]
A Phase 2 trial comparing MAb-3F8 plus GM-CSF to 13-cis-retinoic acid plus GM-CSF in patients with primary refractory neuroblastoma was term…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Multiple Therapies in Treating Patients With Advanced Neuroblastoma [Phase 2]
Clinical trial update reporting Phase 2 results for multiple therapies in patients with advanced neuroblastoma, sponsored by Memorial Sloan …
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma [Phase 1]
This update reports the completion of a Phase 1 trial evaluating ethanol-lock therapy to prevent central venous catheter infections in patie…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Fenretinide in Treating Children With Solid Tumors [Phase 1]
This Clinical Trial Update summarizes a Phase 1 trial of fenretinide in pediatric solid tumors, including neuroblastoma, focusing on safety …
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial of a rebeccamycin analogue in pediatric patients with solid tumors or Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Docetaxel in Treating Children With Recurrent Solid Tumors [Phase 2]
Phase 2 trial evaluating docetaxel in children with recurrent solid tumors has completed; results are summarized in the update.